A
Altimmune D
D
ALT
5.77000
USD
0.61
(11.82%)
مغلق
حجم التداول
219,916
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
444,368,807
العنوان: Altimmune
القطاع: Healthcare
الصناعة: Biotechnology
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.